ニュース
The Food and Drug Administration says it has decided to continue approving COVID-19 vaccine updates for seniors and others at ...
The Food and Drug Administration will no longer approve COVID-19 vaccines for healthy people under 65 without rigorous trials ...
According to the CDC, cases of myocarditis and pericarditis are rare with the vaccines and in most cases resolve within a few ...
FDA leaders say the agency will require more clinical trials to show the benefits of annual COVID shots for healthy adults.
Dr. Anil Diwan, President of NanoViricides, Inc. (NYSE Amer.:NNVC ) (the “Company”), comments on the new COVID Vaccine policy adopted by the US FDA.
2 時間
Amazon S3 on MSNThe FDA Restricts COVID-19 Vaccine Access To High-Risk Groups.The FDA is changing how it approves updated COVID-19 vaccines, limiting their availability to adults 65 and older and ...
Mohave County says they are seeing a surge in Whooping cough cases. FOX5 has reached out to the Southern Nevada Health District to ask about Whooping cough.
"What does Trump think about so-called alternative medicine (SCAM)?" Does anyone know? Does even he know himself? Time to ask GROK! Here is the answer I got when asking exactly that question (the bold ...
Wellbeing Whisper on MSN6 時間
FDA's New Covid-19 Vaccine Strategy Could Leave Millions of Healthy Adults Without Access ...We have to admit to ourselves that America is deeply divided on the policy issue of repeat COVID-19 vaccine doses or boosters ...
While the Trump administration targets COVID-19-related research, a new report from the ECDC shows the benefits of ...
On May 20, 2025, the Food and Drug Administration announced a new stance on who should receive the COVID-19 vaccine.
Moderna, Inc. (NASDAQ:MRNA) made a name for itself by quickly developing an effective coronavirus vaccine when the world needed it the most. However, the stock has largely struggled since the pandemic ...
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する